UK markets closed

NIKKEI 225
38,236.07
-37.98(-0.10%)
HANG SENG
18,207.13
+444.10(+2.50%)
CRUDE OIL
79.06
+0.06(+0.08%)
GOLD FUTURES
2,313.40
+2.40(+0.10%)
DOW
38,225.66
+322.37(+0.85%)
Bitcoin GBP
47,058.75
+1,168.46(+2.55%)

Best UK mortgage deals of the week

The cheapest home loans available now

GILD Jan 2026 77.500 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

15.30

+1.30

(+9.29%)

As of 02:04PM EDT. Market open.

Zacks
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Deciphera Pharmaceuticals, Inc. (DCPH) and GSK are in focus on acquisition news and Q1 earnings, respectively.
Business Wire
Gilead Sciences to Present at Upcoming Investor Conferences
FOSTER CITY, Calif., April 30, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
Insider Monkey
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript April 25, 2024 Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.49. Gilead Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone, and […]